- Report
- March 2024
- 198 Pages
Global
From €3251EUR$3,374USD£2,797GBP
€3612EUR$3,749USD£3,107GBP
- Report
- February 2024
- 137 Pages
Global
From €5733EUR$5,950USD£4,932GBP
- Report
- February 2024
- 115 Pages
Global
From €4577EUR$4,750USD£3,937GBP
- Report
- February 2024
- 185 Pages
Global
From €4722EUR$4,900USD£4,061GBP
The Active Pharmaceutical Ingredient (API) Contract Development and Manufacturing Organization (CDMO) market is a subset of the pharmaceutical intermediates industry. It is composed of companies that specialize in the development and manufacturing of APIs for pharmaceutical products. These companies provide services such as process development, analytical development, and manufacturing of APIs. They also provide support services such as regulatory affairs, quality assurance, and supply chain management.
The API CDMO market is highly competitive, with companies offering a wide range of services and capabilities. Companies in the market are typically large, multinational organizations with extensive experience in the pharmaceutical industry.
Some of the major companies in the API CDMO market include Lonza, Boehringer Ingelheim, Patheon, Cambrex, and Evonik. Show Less Read more